Results of a Phase Iii Clinical Trial of the Human Monoclonal Antibody Mab-t88 Versus Placebo in Gram Negative Sepsis.
Year: 1995
Type: conference-abstract
Source: Critical Care Medicine
Institution: University of California Davis Medical Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2335741422
